Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
San Raffaele University
Fudan University
St. Jude Children's Research Hospital
University of Cincinnati
Women's Hospital School Of Medicine Zhejiang University
UNICANCER
Shanghai Zhongshan Hospital
Sun Yat-sen University
University of Pittsburgh
AIO-Studien-gGmbH
GERCOR - Multidisciplinary Oncology Cooperative Group
Sanford Health
M.D. Anderson Cancer Center
WellSpan Health
Sun Yat-sen University
Ohio State University Comprehensive Cancer Center
University of Pittsburgh
San Raffaele University
Massachusetts General Hospital
Peking University People's Hospital
West China Hospital
The Hospital for Sick Children
Institut Bergonié
Third Affiliated Hospital, Sun Yat-Sen University
University of Colorado, Denver
Sun Yat-sen University